PLATELET-ACTIVATING-FACTOR RECEPTOR AND SIGNAL TRANSDUCTION MECHANISMS

被引:184
作者
SHUKLA, SD
机构
[1] Department of Pharmacology, School of Medicine, University of Missouri, Columbia
关键词
PLATELET-ACTIVATING FACTOR; RECEPTOR; SIGNAL TRANSDUCTION; PHOSPHOLIPASES; PROTEIN KINASES;
D O I
10.1096/fasebj.6.6.1312046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is the most potent phospholipid agonist known to date. Radioligand binding studies using [H-3]PAF and structurally different PAF antagonists have provided the characteristics of PAF receptor(s) and its heterogeneity. Although efforts have been made to isolate the receptor, it was not until the recent cloning of the PAF receptor that the molecular architecture of the receptor can be visualized. The receptor shows homology to the G protein-coupled receptors with seven transmembrane spanning segments. Several serine, threonine, and tyrosine residues are present at the cytoplasmic side, which could serve as sites for phosphorylation. PAF activates GTPase, causes phospholipid turnover via phospholipases C, D, and A2 pathways and also activates protein kinase C and tyrosine kinase. Further, PAF stimulates Ca2+ mobilization some of which may occur via receptor operated channel. Second messengers generated by these multiple signalling pathways play role (or roles) in PAF responses and in the PAF induced expression of primary response genes. These recent developments throw light on the PAF receptor and its signal transduction mechanisms.
引用
收藏
页码:2296 / 2301
页数:6
相关论文
共 42 条
[1]   STIMULATION OF NONSELECTIVE CATION CHANNELS PROVIDING CA2+ INFLUX INTO PLATELETS BY PLATELET-ACTIVATING-FACTOR AND OTHER AGGREGATION INDUCERS [J].
AVDONIN, PV ;
CHEGLAKOV, IB ;
TKACHUK, VA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 198 (01) :267-273
[2]   PLATELET-ACTIVATING FACTOR ANTAGONIST BN52021 DECREASES ACCUMULATION OF FREE POLY-UNSATURATED FATTY-ACID IN MOUSE-BRAIN DURING ISCHEMIA AND ELECTROCONVULSIVE SHOCK [J].
BIRKLE, DL ;
KURIAN, P ;
BRAQUET, P ;
BAZAN, NG .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) :1900-1905
[3]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[4]   CHARACTERIZATION OF H-3-LABELED PLATELET ACTIVATING FACTOR RECEPTOR COMPLEX SOLUBILIZED FROM RABBIT PLATELET MEMBRANES [J].
CHAU, LY ;
JII, YJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 970 (02) :103-112
[5]   PHOTOAFFINITY-LABELING OF PLATELET ACTIVATING FACTOR BINDING-SITES IN RABBIT PLATELET MEMBRANES [J].
CHAU, LY ;
TSAI, YM ;
CHENG, JR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (03) :1070-1076
[6]  
DHAR A, 1990, MOL PHARMACOL, V37, P519
[7]  
DHAR A, 1991, J BIOL CHEM, V266, P18797
[8]  
GANDHI CR, 1990, J BIOL CHEM, V265, P18234
[9]   INTERCELLULAR COMMUNICATION WITHIN THE LIVER HAS CLINICAL IMPLICATIONS [J].
GARCIASAINZ, JA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (01) :10-11
[10]  
GLASER KB, 1990, J BIOL CHEM, V265, P8658